Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Repeated daunomycin administration in rats

Pharmacokinetics and bone marrow toxicity

  • 11 Accesses

  • 5 Citations

Summary

In the experiments described here, rats received three IV bolus injections (7.5 mg/kg) of daunomycin. The plasma data obtained after a single IV injection could be described by a two-compartment open model with t1/2α and t1/2β values of 18.4 and 472.1 min. Of the tissues, the lungs contained the most daunomycin per gram of tissue, followed by the kidneys, liver, heart, and spleen. Daunomycinol was the main metabolic product and no substantial differences were found in daunomycinol content among the different organs. For all tissues and plasma, higher drug concentration values than would be expected on the basis of accumulation alone were observed after the second but not after the third injection. The cumulative urine excretion of daunomycin and daunomycinol remained essentially unchanged after one, two, and three daunomycin injections. However, the cumulative bile excretion incrased after repeated daunomycin administration. The experiments in which the myelotoxicity was assessed by CFU-S survival after daunomycin treatment showed that three successive daunomycin administrations lead to a proportional reduction in stem cells.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Baurain R, Deprez-de Campeneere D, Trouet A (1979) Determination of daunorubicin, doxorubicine and their fluorescent metabolites by high-pressure liquid chromatography. Cancer Chemother Pharmacol 2: 11

  2. 2.

    Blum RH, Carter SK (1974) Adriamycin: a new antitumor drug with significant clinical activity. Ann Intern Med 80: 249

  3. 3.

    Carter SK (1975) Adriamycin — a review. J Natl Cancer Inst 55: 1265

  4. 4.

    DiMarco A (1982) Anthracycline antibiotics. In: Holland JF, Frei E III (eds) Cancer medicine. Lea & Febiger, Philadelphia, p 872

  5. 5.

    Hagenbeek A, Martens ACM (1981) The proliferative state of normal hemopoietic stem cells during progression of leukemia. Studies in the BN acute myelocytic leukemia (BNML). Leuk Res 5: 141

  6. 6.

    O'Bryan RM, Baker LH, Gottlieb JE, Rivkin SE, Balcerzak SP, Grummet GN (1977) Dose-response evaluation of adriamycin in human neoplasia. Cancer 39: 1940

  7. 7.

    Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Hamilton Press, Hamilton (Drug intelligence publications)

Download references

Author information

Correspondence to Kees Nooter.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nooter, K., Sonneveld, P., Deurloo, J. et al. Repeated daunomycin administration in rats. Cancer Chemother. Pharmacol. 12, 187–189 (1984). https://doi.org/10.1007/BF00256543

Download citation

Keywords

  • Stem Cell
  • Cancer Research
  • Drug Concentration
  • Open Model
  • Urine Excretion